Aldurazyme (Laronidase) - Current Clinical Trials

Aldurazyme Related Clinical Trials

A Dose-Optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease [Completed]

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients [Completed]

A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old [Completed]

Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease [Completed]

A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG Levels in Aldurazyme® Treated Patients [Recruiting]

A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [Recruiting]

Immune Tolerance Study With Aldurazyme® [Recruiting]

Stem Cell Transplant w/Laronidase for Hurler [Recruiting]

A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I [Recruiting]

Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I [Recruiting]

Intrathecal Enzyme Replacement for Hurler Syndrome [Recruiting]

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I [Recruiting]

Mucopolysaccharidosis I (MPS I) Registry [Recruiting]